| Literature DB >> 31807124 |
Meng-Chuan Huang1,2, Chiao-I Chang2, Wen-Tsan Chang3,4, Yen-Ling Liao2, Hsin-Fang Chung5, Chih-Cheng Hsu6, Shyi-Jang Shin3,7, Kun-Der Lin7,8.
Abstract
BACKGROUND: Metabolic alterations correlate with adverse outcomes in type 2 diabetes. Dietary modification serves as an integral part in its treatment.Entities:
Keywords: Taiwan; dietary pattern; ferritin; n-3 PUFA; type 2 diabetes
Year: 2019 PMID: 31807124 PMCID: PMC6878969 DOI: 10.29219/fnr.v63.3592
Source DB: PubMed Journal: Food Nutr Res ISSN: 1654-661X Impact factor: 3.894
Correlations between quartiles of dietary patterns and demographic characteristic and metabolic parameters in type 2 diabetes (N = 871)
| Patient characteristics | High-fat meat diet | Traditional Chinese food–snack diet | Fish–vegetable diet | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q4 | Q1 | Q4 | Q1 | Q4 | ||||
| Age (years) | |||||||||
| <65 | 116 (53.5) | 175 (80.6) | <0.001 | 112 (51.6) | 163 (74.8) | <0.001 | 152 (70.0) | 121 (55.8) | 0.012 |
| ≥65 | 101 (46.5) | 42 (19.4) | 105 (48.4) | 55 (25.2) | 65 (30.0) | 96 (44.2) | |||
| Gender | |||||||||
| Male | 58 (26.7) | 151 (69.6) | <0.001 | 103 (47.5) | 98 (45.0) | 0.935 | 113 (52.1) | 100 (46.1) | 0.155 |
| Female | 159 (73.3) | 66 (30.4) | 114 (52.5) | 120 (55.0) | 104 (47.9) | 117 (53.9) | |||
| Education year | |||||||||
| ≤6 | 139 (64.1) | 73 (33.6) | <0.001 | 155 (71.4) | 100 (45.9) | <0.001 | 104 (47.9) | 125 (57.6) | 0.033 |
| >6 | 78 (35.9) | 144 (66.4) | 62 (28.6) | 118 (54.1) | 113 (52.1) | 92 (42.4) | |||
| BMI (kg/m2) | |||||||||
| <24 | 74 (34.1) | 64 (29.5) | 0.773 | 67 (31.2) | 66 (30.4) | 0.936 | 65 (30.1) | 69 (31.9) | 0.941 |
| ≥24 | 143 (65.9) | 153 (70.5) | 148 (68.8) | 151 (69.6) | 151 (69.9) | 147 (68.1) | |||
| Diabetes duration (years) | |||||||||
| <7 | 64 (29.5) | 83 (38.8) | 0.103 | 48 (22.6) | 79 (36.7) | 0.006 | 73 (33.6) | 61 (28.4) | 0.379 |
| ≥7 | 153 (70.5) | 131 (61.2) | 168 (77.4) | 135 (63.3) | 144 (66.4) | 154 (71.6) | |||
| Smoking | |||||||||
| Yes | 30 (13.8) | 117 (53.9) | <0.001 | 64 (29.8) | 76 (34.9) | 0.410 | 85 (39.4) | 76 (35.0) | 0.003 |
| No | 187 (86.2) | 100 (46.1) | 151 (70.2) | 142 (65.1) | 131 (60.6) | 141 (65.0) | |||
| Alcohol drinking | |||||||||
| Yes | 12 (5.5) | 58 (26.7) | <0.001 | 20 (9.3) | 30 (13.8) | 0.225 | 25 (11.6) | 33 (15.2) | 0.726 |
| No | 205 (94.5) | 159 (73.3) | 195 (90.7) | 188 (86.2) | 191 (88.4) | 184 (84.8) | |||
Chi-square tests were used to examine differences in quartile 1 to quartile 4.
Data were expressed as N (%). P < 0.05 was considered significant.
BMI, Body mass index.
Metabolic parameters in 871 patients with type 2 diabetes analyzed by quartile levels of dietary pattern score
| Quartiles of dietary patterns | ||||||
|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | |||
| Metabolic parameters | ||||||
| SBP (mmHg) | 135.8 ± 19.1 | 136.3 ± 20.0 | 134.5 ± 17.7 | 135.9 ± 16.4 | 0.766 | 0.659 |
| DBP (mmHg) | 76.1 ± 10.4 | 76.7 ± 11.1 | 78.9 ± 10.4 | 81.9 ± 9.3 | <0.001 | <0.001 |
| Fasting plasma glucose (mg/dL) | 146.6 ± 50.5 | 145.2 ± 51.8 | 153.4 ± 56.9 | 161.2 ± 60.0 | 0.009 | <0.001 |
| Hemoglobin A1c (%) | 7.8 ± 1.5 | 7.7 ± 1.6 | 7.9 ± 1.6 | 8.0 ± 1.6 | 0.181 | 0.007 |
| Triglyceride (mg/dL) | 168.7 ± 108.9 | 149.7 ± 76.4 | 149.1 ± 115.2 | 181.2 ± 146.2 | 0.007 | 0.250 |
| Cholesterol (mg/dL) | 194.7 ± 39.1 | 196.9 ± 37.4 | 192.9 ± 35.7 | 194.7 ± 39.3 | 0.745 | 0.720 |
| HDL-C (mg/dL) | 49.1 ± 12.5 | 49.8 ± 12.1 | 49.4 ± 12.3 | 44.9 ± 11.4 | <0.001 | 0.003 |
| Dietary biomarkers | ||||||
| Ferritin (ng/mL) | 165.8 ± 150.4 | 172.2 ± 131.7 | 190.6 ± 168.6 | 247.5 ± 222.5 | <0.001 | <0.001 |
| Folate (ng/mL) | 11.6 ± 12.3 | 8.5 ± 6.4 | 8.7 ± 5.8 | 8.7 ± 10.2 | 0.002 | 0.006 |
| n-3 PUFA | 9.5 ± 2.3 | 10.2 ± 1.4 | 10.3 ± 1.6 | 10.7 ± 1.8 | <0.001 | <0.001 |
| EPA+DHA | 7.2 ± 2.1 | 7.9 ± 1.3 | 8.0 ± 1.4 | 8.3 ± 1.6 | <0.001 | <0.001 |
| n-3/n-6 PUFA ratio | 0.31 ± 0.09 | 0.34 ± 0.06 | 0.34 ± 0.7 | 0.34 ± 0.7 | <0.001 | <0.001 |
| Metabolic parameters | ||||||
| SBP (mmHg) | 137.5 ± 18.9 | 135.2 ± 18.2 | 134.9 ± 19.0 | 135.0 ± 17.2 | 0.378 | 0.026 |
| DBP (mmHg) | 77.6 ± 10.2 | 77.8 ± 11.4 | 78.2 ± 10.9 | 80.1 ± 9.4 | 0.046 | 0.057 |
| Fasting plasma glucose (mg/dL) | 154.9 ± 58.3 | 143.4 ± 45.5 | 147.4 ± 52.7 | 160.7 ± 61.8 | 0.005 | 0.370 |
| Hemoglobin A1c (%) | 8.0 ± 1.6 | 7.6 ± 1.4 | 7.8 ± 1.6 | 8.1 ± 1.6 | 0.014 | 0.539 |
| Triglyceride (mg/dL) | 149.3 ± 75.5 | 151.9 ± 86.5 | 169.0 ± 133.9 | 178.2 ± 145.9 | 0.024 | 0.022 |
| Cholesterol (mg/dL) | 194.9 ± 36.7 | 193.4 ± 37.5 | 194.4 ± 38.3 | 196.5 ± 39.2 | 0.864 | 0.936 |
| HDL-C (mg/dL) | 48.9 ± 11.6 | 49.1 ± 13.2 | 47.9 ± 12.7 | 47.4 ± 11.3 | 0.410 | 0.051 |
| Dietary biomarkers | ||||||
| Ferritin (ng/mL) | 191.7 ± 162.8 | 185.4 ± 131.4 | 201.5 ± 198.0 | 198.9 ± 199.7 | 0.806 | 0.695 |
| Folate (ng/mL) | 8.8 ± 6.2 | 10.1 ± 12.9 | 9.3 ± 9.8 | 9.2 ± 6.2 | 0.577 | 0.848 |
| n-3 PUFA | 11.1 ± 1.7 | 10.3 ± 1.7 | 10.1 ± 1.7 | 9.5 ± 1.9 | <0.001 | <0.001 |
| EPA+DHA | 8.7 ± 1.4 | 8.0 ± 1.5 | 7.7 ± 1.5 | 7.2 ± 1.8 | <0.001 | <0.001 |
| n-3/n-6 PUFA ratio | 0.37 ± 0.07 | 0.34 ± 0.07 | 0.32 ± 0.07 | 0.29 ± 0.07 | <0.001 | <0.001 |
| Metabolic parameters | ||||||
| SBP (mmHg) | 135.4 ± 18.5 | 136.0 ± 18.5 | 134.5 ± 17.9 | 136.7 ± 18.4 | 0.629 | 0.700 |
| DBP (mmHg) | 78.2 ± 10.8 | 78.2 ± 10.2 | 78.1 ± 10.7 | 79.2 ± 10.5 | 0.649 | 0.577 |
| Fasting plasma glucose (mg/dL) | 148.4 ± 52.7 | 154.2 ± 56.7 | 154.3 ± 54.1 | 149.4 ± 57.4 | 0.554 | 0.901 |
| Hemoglobin A1c (%) | 7.9 ± 1.5 | 7.9 ± 1.7 | 7.9 ± 1.4 | 7.8 ± 1.6 | 0.989 | 0.397 |
| Triglyceride (mg/dL) | 176.9 ± 132.5 | 168.2 ± 138.8 | 153.1 ± 87.7 | 150.4 ± 89.9 | 0.050 | <0.001 |
| Cholesterol (mg/dL) | 196.1 ± 39.1 | 195.2 ± 36.9 | 193.0 ± 35.9 | 194.9 ± 39.5 | 0.855 | 0.399 |
| HDL-C (mg/dL) | 47.3 ± 11.7 | 48.8 ± 12.6 | 48.9 ± 12.0 | 48.3 ± 12.6 | 0.552 | 0.128 |
| Dietary biomarkers | ||||||
| Ferritin (ng/mL) | 197.4 ± 180.8 | 199.9 ± 202.9 | 186.6 ± 162.5 | 193.3 ± 149.5 | 0.888 | 0.350 |
| Folate (ng/mL) | 9.7 ± 13.1 | 9.1 ± 6.4 | 8.9 ± 5.9 | 9.6 ± 9.5 | 0.799 | 0.892 |
| n-3 PUFA | 9.6 ± 1.7 | 9.8 ± 1.7 | 10.1 ± 1.6 | 11.3 ± 1.8 | <0.001 | <0.001 |
| EPA+DHA | 7.3 ± 1.5 | 7.5 ± 1.5 | 7.8 ± 1.4 | 8.9 ± 1.6 | <0.001 | <0.001 |
| n-3/n-6 PUFA ratio | 0.31 ± 0.07 | 0.32 ± 0.07 | 0.33 ± 0.06 | 0.37 ± 0.07 | <0.001 | <0.001 |
ANOVA was used to examine differences among quartile 1, 2, 3, and 4 levels.
Simple linear regression was used to examine the trend between metabolic parameters or dietary biomarkers against four quartile levels of three major dietary patterns.
Data were expressed as mean ± SD and P < 0.05 was considered significant.
Association between dietary biomarkers and metabolic parameters after adjustment for confounders by multiple liner regression
| Ferritin (ng/mL) | Folate (ng/mL) | n-3 PUFA | EPA+DHA | n-3/n-6 PUFA ratio | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Fasting plasma glucose (mg/dL) | ||||||||||
| Crude model | 0.055 (0.011) | <0.001 | 0.465 (0.211) | 0.028 | −1.737 (1.226) | 0.157 | −1.924 (1.347) | 0.154 | −49.002 (30.307) | 0.106 |
| Model 1[ | 0.061 (0.012) | <0.001 | 0.432 (0.210) | 0.040 | −2.903 (1.309) | 0.027 | −3.124 (1.431) | 0.029 | −64.715 (31.980) | 0.043 |
| Model 2[ | 0.062 (0.012) | <0.001 | 0.456 (0.212) | 0.032 | −2.943 (1.310) | 0.025 | −3.224 (1.432) | 0.025 | −66.494 (31.947) | 0.038 |
| Hemoglobin A1c × 10 (%) | ||||||||||
| Crude model | 0.007 (0.003) | 0.037 | 0.067 (0.060) | 0.263 | −0.877 (0.343) | 0.011 | −0.895 (0.377) | 0.018 | −25.211 (8.464) | 0.003 |
| Model 1[ | 0.007 (0.003) | 0.027 | 0.056 (0.060) | 0.351 | −1.308 (0.365) | <0.001 | −1.333 (0.399) | 0.001 | −33.048 (8.901) | <0.001 |
| Model 2[ | 0.008 (0.003) | 0.020 | 0.068 (0.061) | 0.265 | −1.296 (0.367) | <0.001 | −1.336 (0.401) | 0.001 | −32.991 (8.927) | <0.001 |
| Triglyceride (mg/dL) | ||||||||||
| Crude model | 0.213 (0.021) | <0.001 | 0.699 (0.419) | 0.095 | −12.02 8 (2.541) | <0.001 | −13.104 (2.794) | <0.001 | −177.51 (63.629) | 0.005 |
| Model 1[ | 0.231 (0.022) | <0.001 | 0.800 (0.424) | 0.060 | −14.300 (2.772) | <0.001 | −15.390 (3.032) | <0.001 | −200.81 (68.704) | 0.004 |
| Model 3[ | 0.240 (0.022) | <0.001 | 0.637 (0.424) | 0.134 | −15.952(2.766) | <0.001 | −17.064 (3.032) | <0.001 | −236.70 (68.851) | 0.001 |
| HDL-C (mg/dL) | ||||||||||
| Crude model | −0.015 (0.002) | <0.001 | 0.066 (0.047) | 0.162 | 0.469 (0.276) | 0.090 | 0.545 (0.303) | 0.073 | 8.407 (6.833) | 0.219 |
| Model 1[ | −0.010 (0.002) | <0.001 | 0.006 (0.046) | 0.888 | 0.704 (0.284) | 0.014 | 0.736 (0.311) | 0.018 | 13.245 (6.961) | 0.058 |
| Model 3[ | −0.010 (0.002) | <0.001 | 0.011 (0.046) | 0.819 | 0.726 (0.290) | 0.013 | 0.756 (0.318) | 0.018 | 13.723 (7.113) | 0.054 |
Model 1 was adjusted for demographic characteristic (age, gender, body mass index, diabetes duration, education, and energy intake).
Model 2 was adjusted for confounders in model 1 plus hypertension and hypoglycemic agents use.
Model 3 was adjusted for confounders in model 1 plus hypertension, hypolipidemic, and hypoglycemic agents use.
Data were expressed as beta (SE) and P < 0.05 was considered significantly different.